SMTL ID : 5lyy.1

Fragment-based inhibitors of Lipoprotein associated Phospholipase A2

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.17 Å

Oligo State

monomer

Ligands

1 x 7BJ: 3-[2-(4-fluoranylphenoxy)ethyl]-1,3-diazaspiro[4.5]decane-2,4-dione(Non-covalent)

7BJ.1: 17 residues within 4Å: Chain A: L.62, F.65, G.107, L.108, G.109, A.110, L.114, Y.115, H.227, S.228, F.229, W.253, F.277, H.306, Q.307, A.310, F.312 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:F.65, A:L.108, A:A.110, A:L.114, A:W.253, A:F.277, A:F.277, A:A.310 Hydrogen bonds: A:L.108, A:S.228, A:F.229, A:Q.307

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Woolford, A.J. et al., Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2). J. Med. Chem. (2016)

Release Date

2016-12-21

Peptides

Platelet-activating factor acetylhydrolase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Platelet-activating factor acetylhydrolase

Related Entries With Identical Sequence